Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for March 22nd

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 22nd:

Spirit AeroSystems Holdings, Inc. (SPR - Free Report) : This commercial aero structures manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.

Spirit AeroSystems has a PEG ratio 1.56, compared with 2.37 for the industry. The company possesses a Growth Score of A.

Sysco Corporation (SYY - Free Report) : This food and related products marketer and distributor, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.

Sysco has a PEG ratio 1.87, compared with 2.39 for the industry. The company possesses a Growth Score of A.

CECO Environmental Corp. (CECE - Free Report) : This industrial air quality and fluid handling systems provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.

CECO Environmental has a PEG ratio 1.06, compared with 1.28 for the industry. The company possesses a Growth Score of A.

AeroVironment, Inc. (AVAV - Free Report) : This unmanned aircraft systems and related services provider, which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.

AeroVironment has a PEG ratio 1.67, compared with 2.37 for the industry. The company possesses a Growth Score of B.

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



More from Zacks Zacks #1 Rank Additions

You May Like

Published in